We are live on ! Find out more
PCM

Portolan Capital Management Portfolio holdings

AUM $1.88B
1-Year Est. Return 115.74%
This Fund
S&P 500
This Quarter Est. Return
+14.65%
1 Year Est. Return
+115.74%
3 Year Est. Return
+581.85%
5 Year Est. Return
+1,047.01%
10 Year Est. Return
+13,266.68%
AUM
$1.01B
AUM Growth
+$61.8M
Cap. Flow
-$18M
Cap. Flow %
-1.78%
Top 10 Hldgs %
24.73%
Holding
166
New
38
Increased
40
Reduced
49
Closed
35

Top Buys

Rank Stock Value
1
RPAY icon
Repay Holdings
RPAY
+$15.3M
2
EEFT icon
Euronet Worldwide
EEFT
+$14.4M
3
SMCI icon
Super Micro Computer
SMCI
+$13.6M
4
ETWO
E2open Parent Holdings
ETWO
+$11.9M
5
HROW icon
Harrow
HROW
+$11.6M

Top Sells

Rank Stock Value
1
LRN icon
Stride
LRN
+$21.5M
2
CF icon
CF Industries
CF
+$19.9M
3
RCM
R1 RCM Inc. Common Stock
RCM
+$15.1M
4
NTRA icon
Natera
NTRA
+$13.7M
5
ORCL icon
Oracle
ORCL
+$13.1M

Sector Composition

Rank Sector Weight
1 Technology 31.98%
2 Consumer Discretionary 15.84%
3 Healthcare 11.73%
4 Industrials 8.83%
5 Consumer Staples 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRVA icon
151
Privia Health
PRVA
$2.87B
– –
-208,807
Closed -$7.11M
SFL icon
152
SFL Corp
SFL
$1.61B
– –
-387,371
Closed -$3.53M
SKIN icon
153
SkinHealth Systems
SKIN
$85.7M
– –
-390,599
Closed -$4.61M
SQM icon
154
Sociedad Química y Minera de Chile
SQM
$20.6B
– –
-139,019
Closed -$12.6M
STAA icon
155
STAAR Surgical
STAA
$1.21B
– –
-61,583
Closed -$4.34M
SSYS icon
156
Stratasys
SSYS
$774M
– –
-145,936
Closed -$2.1M
TMO icon
157
Thermo Fisher Scientific
TMO
$220B
– –
-12,814
Closed -$6.5M
TRIP icon
158
TripAdvisor
TRIP
$1.26B
– –
-346,858
Closed -$7.66M
VET icon
159
Vermilion Energy
VET
$1.66B
– –
-212,091
Closed -$4.54M
ONIT
160
Onity Group
ONIT
$332M
– –
-32,734
Closed -$762K
CTLT
161
DELISTED
CATALENT, INC.
CTLT
– –
-74,842
Closed -$5.42M
RCM
162
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-816,515
Closed -$15.1M
CAMP
163
DELISTED
CalAmp Corp.
CAMP
– –
-12,495
Closed -$1.1M
LFG
164
DELISTED
Archaea Energy Inc.
LFG
– –
-202,909
Closed -$3.65M
ABMD
165
DELISTED
Abiomed Inc
ABMD
– –
-7,139
Closed -$1.75M
AGTC
166
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-1,600,902
Closed -$435K
3 4 5 6
7

Similar funds

JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

Portolan Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Portolan Capital Management held 166 positions worth $1.01B, up 6.5% from $946M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Portolan Capital Management's Q4 2022 filing shows 38 new, 40 increased, 49 reduced and 35 closed positions. Its largest new stake was Euronet Worldwide: 166,590 shares worth $15.7M. The largest sale was Stride, an estimated $21.5M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Portolan Capital Management's largest Q4 2022 buy was Euronet Worldwide: 166,590 shares worth $15.7M.
  • Portolan Capital Management added most to Repay Holdings in Q4 2022, an estimated $15.3M increase.
  • Portolan Capital Management's biggest Q4 2022 reduction was Stride, cutting an estimated $21.5M.
  • Portolan Capital Management fully exited CF Industries in Q4 2022, selling an estimated $19.9M.
  • Portolan Capital Management's ten largest holdings make up 25% of its $1.01B portfolio in Q4 2022.
  • Portolan Capital Management opened 38 new positions and closed 35 in Q4 2022.
  • Portolan Capital Management's portfolio value rose 6.5% quarter-over-quarter to $1.01B.

Based on Portolan Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.